The Chinese University of Hong Kong (CUHK) has established a new collaboration with a leading Australia-based medical research institute aimed at enhancing the health impact agenda in the Guangdong – Hong Kong – Macau Greater Bay Area (GBA) and beyond.
The partnership seeks to transform healthcare in the region and address global health challenges. This initiative will focus on creating innovative solutions that can be implemented in the GBA and scaled globally to achieve better health outcomes. With this collaboration, CUHK seeks to expand its research and improve its ability to develop and implement evidence-based policies and programs that address pressing health issues.
The independent non-profit medical research organisation that specialises in non-communicable diseases and injuries, has partnered with CUHK in their effort to enhance the health impact agenda in the Guangdong – Hong Kong – Macau Greater Bay Area (GBA) and worldwide.
For a period of twelve months, CUHK and the independent non-profit medical research organisation will work collaboratively to address various health issues, including neurodegenerative diseases, mental health, multimorbidity, health economics, primary care, trauma, and injury.
This partnership aims to leverage the expertise of both organisations to use biotechnology among other methodologies to develop innovative solutions that can be implemented in the GBA and beyond. By working together, CUHK and the non-profit organisation seek to create evidence-based policies and programs that will lead to improved health outcomes in the region and globally.
The two will jointly conduct research, clinical trials, and advocacy for healthcare systems. Together, they will use their collective expertise to address the leading causes of disease burden in the Greater Bay Area and globally. By combining their resources, the two seek to develop innovative solutions that can improve health outcomes and reduce the burden of disease in the region and beyond.
CUHK’s Vice-Chancellor and President stated that the University and its industry partner is an exciting opportunity to bring about targeted interventions and clinical breakthroughs that can improve the health and wellbeing of people in the Greater Bay Area and beyond.
He said that the collaboration is a testament to CUHK’s renowned expertise in medicine and Hong Kong’s pivotal role as a ‘superconnector’ linking global research talent to advance the country’s development. Together, CUHK and the non-profit organisation seek to make a positive impact on public health and transform healthcare for the benefit of all.
Meanwhile, the Chief Executive Officer of the non-profit organisation stated that the non-profit medical research organisation is pleased to announce its collaboration with CUHK. By drawing on the distinct strengths of both institutions, this partnership will enable them to work together on critical healthcare issues.
The collaboration exemplifies the non-profit organisation’s approach to partnering with leading academic institutions worldwide to fulfil its mission of improving the lives of millions of people globally. Together, CUHK and the non-profit organisation seek to create positive change in public health and make a significant impact on the future of healthcare.
The partnership, overall, is an exciting development in the advancement of healthcare in the Greater Bay Area and beyond. By working together, these institutions bring together their wealth of experience and resources to address pressing healthcare issues, such as neurodegenerative diseases, mental health, multimorbidity, health economics, primary care, trauma, and injury.
Through joint research, clinical trials, and advocacy, CUHK and the non-profit organisation seek to develop innovative solutions using the latest biotechnologies that can be scaled globally, driving better health outcomes and reducing the burden of disease. This partnership represents a significant step forward in the quest for improved public health and the transformation of healthcare worldwide.
